The GOAT ETF Review: VanEck’s AI Powered Global Equity ETF Explained
A Simple Way to Add AI to Your Global Equity Portfolio Artificial intelligence has quickly become one of the biggest investment themes in global markets.…
Most Popular
Grow your wealth. Expand your knowledge. Leverage strategic insight.
The Investor Standard delivers world-class market analysis, stock recommendations, and exclusive insights to help you make smarter investment decisions and stay ahead of the market.
Japan’s Finally Got What It Wanted, Now It Has A New Problem
For more than three decades, Japan fought deflation through one of history's most aggressive monetary experiments. Now inflation has finally…
Bending Spoons IPO 2026: The Rise of Europe’s Software Roll-Up Platform Heading to Nasdaq
A software roll-up arriving at public markets Bending Spoons is preparing for one of the most structurally interesting software IPOs…
ASX momentum stocks 2026: Data Centres, Critical Minerals, and Speculative Heat on the ASX
Australia’s equity market is increasingly splitting into two distinct behaviours. The ASX 20 continues to drive index stability, while much…
Main Capital Partners Closes Record €5.25bn Software Fundraise in Under Six Months
A Milestone moment for the european software business
Markets
What Happened To Thailand’s Economy?
Once one of Asia's fastest-growing economies, Thailand is now struggling to keep pace with its Southeast Asian neighbours. Here's what happened—and what it will take…
Highlighted Insights
Beyond Lithium, A Pragmatic Guide to ASX Critical Minerals
Every Australian investor now “knows” lithium. The harder question is where the next wave of critical minerals alpha comes from, and how to avoid getting…
QUAL ETF: The Quality Label Hiding a Big Tech Bet
A quality label, a big tech portfolio, and five times the fee.
This Month in Venture Capital
The venture capital market has entered a different phase. Capital has returned, but the easy money environment that defined previous…
Featured Investments (Stock Picks)
ASX REIT Sector Outlook
The A-REIT sector went through a difficult 2025, with the S&P/ASX 200 A-REIT Index falling…
ASX Stocks in Focus: Five Quality Names Beyond the Usual Trade
Positioning portfolios beyond momentum.
Unlock Smarter Investing
Gain access to independent ASX insights, exclusive stock picks, and in-depth research trusted by founders, boards, and investors.
An Outlook on ASX: Ramsay Health Care (RHC)
Business Summary & Overview Ramsay Health Care is a prominent international hospital operator offering acute…
ASX Weekly Market Wrap
A Bounce, But Not a Clean Recovery Australian equities finally broke their losing streak, with…
Investor Insights, Delivered
Unlock expert insights, stock recommendations, and market analysis – all in one place. Get the latest market news and stock picks instantly.
Explore More Insights
Project Vault and Australia’s Critical Minerals: Why US Capital is Reshaping the Sector
The US push to secure supply chains for critical minerals has taken a sharp turn from rhetoric to capital. President…
ASX Industrials Sector Analysis: The Quiet Sector Still Building Australia
The ASX industrials sector rarely gets the same attention as miners or high-growth technology names, but it remains one of…
Infratil (IFT): Dissecting Australia’s Newest Infrastructure Investment Platform
Business Overview Infratil Limited is a New Zealand–based global infrastructure investment company with a diversified portfolio spanning digital infrastructure, renewable…
Unemployment Falls to 4.1% as Youth Drive Hiring
Australia’s labour market finished 2025 on a strong note, with the unemployment rate sliding to 4.1% in December from 4.3%…
Monash IVF Shares Rose on a Profit Cut. That Tells You What the Market Stopped Caring About
Reaction (12 Jun 2026) +2.2% Price (17 Jun 2026) A$0.73 FY26 NPAT guide A$17–18m Market cap ~A$284m Rejected bids 80c…
Investment Analysis: Mesoblast Ltd (ASX: MSB)
Business Summary Mesoblast Limited specializes in developing allogeneic, “off‑the‑shelf” cellular medicines designed to treat severe inflammatory conditions. The company’s late‑stage…
Socials
Monthly Investor Memo
Delivered Monthly - 2026